GSK SAS11538

Mar 3, 2021

Started: 1/2012

Study Name: A 6-Month Safety And Benefit Study Of Inhaled xxx Combination Versus Inhaled xxx In The Treatment Of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma”

Indication: Asthma

Principal Investigator: Brad Brabec

This study is no longer active

Current Studies